Literature DB >> 26461987

Community Approaches to the Opioid Crisis.

Howard Koh1.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 26461987     DOI： 10.1001/jama.2015.12346

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  5 in total

1.  Patterns of adolescent tobacco and alcohol use as predictors of illicit and prescription drug abuse in minority young adults.

Authors:  Kenneth W Griffin; Sarah R Lowe; Caroline Botvin; Bianca P Acevedo
Journal:  J Prev Interv Community       Date:  2019-04-25

2.  Trends in Abstinence and Retention Associated with a Medication-Assisted Treatment Program for People with Opioid Use Disorders.

Authors:  Kimberly D Brunisholz; Andrew J Knighton; Amulya Sharma; Lisa Nichols; Kristen Reisig; Jed Burton; Debbie Scovill; Carolyn Tometich; Mark Foote; Shelly Read; Scott Whittle
Journal:  Prog Community Health Partnersh       Date:  2020

3.  Preclinical Testing of Nalfurafine as an Opioid-sparing Adjuvant that Potentiates Analgesia by the Mu Opioid Receptor-targeting Agonist Morphine.

Authors:  Shane W Kaski; Allison N White; Joshua D Gross; Kristen R Trexler; Kim Wix; Aubrie A Harland; Thomas E Prisinzano; Jeffrey Aubé; Steven G Kinsey; Terry Kenakin; David P Siderovski; Vincent Setola
Journal:  J Pharmacol Exp Ther       Date:  2019-09-06       Impact factor: 4.030

4.  Integrating Treatment at the Intersection of Opioid Use Disorder and Infectious Disease Epidemics in Medical Settings: A Call for Action After a National Academies of Sciences, Engineering, and Medicine Workshop.

Authors:  Sandra A Springer; P Todd Korthuis; Carlos Del Rio
Journal:  Ann Intern Med       Date:  2018-07-13       Impact factor: 25.391

5.  Role of RGS12 in the differential regulation of kappa opioid receptor-dependent signaling and behavior.

Authors:  Joshua D Gross; Shane W Kaski; Karl T Schmidt; Elizabeth S Cogan; Kristen M Boyt; Kim Wix; Adam B Schroer; Zoe A McElligott; David P Siderovski; Vincent Setola
Journal:  Neuropsychopharmacology       Date:  2019-05-29       Impact factor: 7.853
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.